1. Announcement of changes to the Editorial Board

   Announcement 24 November 2022 Pages: 579 - 579

2. James Saville Wiley (1936–2022): pioneer of purinergic research in Australia and abroad

   • Ben J. Gu
   • Stephen J. Fuller
   • Ronald Sluyter

   Correspondence 17 July 2023 Pages: 581 - 585

   

3. A promising drug for neuropathic pain: identification of vesicular nucleotide transporter as a novel target of eicosapentaenoic acid

   • Kozo Saito
   • Schuichi Koizumi

   Journal Club 11 January 2023 Pages: 587 - 589

4. A_2A receptor signaling drives cisplatin-mediated hippocampal neurotoxicity and cognitive defects in mice

   • Benjamin B. Gyau
   • Silvia Deaglio

   Journal Club 14 January 2023 Pages: 591 - 593

5. Third meeting of the Australian and New Zealand Purine Club

   • Reece A. Sophocleous
   • Ronald Sluyter
   • Jennie M. E. Cederholm

   Brief Communication Open access 18 August 2023 Pages: 595 - 598

6. EU COST Action CA21130 PRESTO ‘P2X receptors as therapeutic targets’ inaugural meeting report

   • Luke Tattersall
   • Ankita Agrawal
   • Alison Gartland

   Brief Report Open access 15 July 2023 Pages: 599 - 611

   

7. Transactivation of receptor tyrosine kinases by purinergic P2Y and adenosine receptors

   • F. G. Vázquez-Cuevas
   • M. Reyna-Jeldes
   • C. Coddou

   Review Article 19 December 2022 Pages: 613 - 621

   

8. Adenosine A₁ receptor antagonist-induced facilitation of postsynaptic AMPA currents in pyramidal neurons of the rat hippocampal CA2 area

   • Masahito Kawamura Jr.
   • Yuko Sekino

   Original Article 08 September 2022 Pages: 623 - 632

   

9. Istradefylline modulates purinergic enzymes and reduces malignancy-associated factors in B16F10 melanoma cells

   • Jean Lucas Gutknecht da Silva
   • Altevir Rossato Viana
   • Daniela Bitencourt Rosa Leal

   Original Article 16 December 2022 Pages: 633 - 650

   

10. ATP breakdown in plasma of children limits the antimicrobial effectiveness of their neutrophils

    • Carola Ledderose
    • Eleftheria-Angeliki Valsami
    • Wolfgang G. Junger

    Original Article 04 January 2023 Pages: 651 - 662

    

11. Genetic polymorphisms of purinergic P2Y₂ receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women

    • Ao Li
    • Chaopeng Xiong
    • Hong Xu

    Original Article 19 January 2023 Pages: 663 - 671

    

12. The striatum drives the ergogenic effects of caffeine

    • Ana Cristina de Bem Alves
    • Ana Elisa Speck
    • Aderbal S Aguiar Jr

    Original Article 26 January 2023 Pages: 673 - 683

    

13. P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways

    • Xue Bai
    • Qianqian Li
    • Ronglan Zhao

    Original Article 01 March 2023 Pages: 685 - 697

    

14. P2X7 receptor antagonist A-438079 alleviates oxidative stress of lung in LPS-induced septic rats

    • Seckin Ozkanlar
    • Nergis Ulas
    • Emine Satici

    Research 24 March 2023 Pages: 699 - 707

    

15. Retraction Note: Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation

    • Ahmed M. Youssef
    • Dong-Keun Song

    Retraction Note 12 August 2023 Pages: 709 - 709

16. Retraction Note: Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells

    • Mariachiara Zuccarini
    • Patricia Giuliani
    • Patrizia Di Iorio

    Retraction Note 29 September 2023 Pages: 711 - 711